2024-05-13T11:54:51-00:00 2023-06-30 834701972 LEWIS SHARPSTONE & CO 5850 CANOGA AVE SUITE 400 WOODLAND HILLS CA 91367 990 2022-07-01 561683450 SOLVE ME CFS INITIATIVE INC SOLV 7043640016 350 N GLENDALE BLVD SUITE B STE 368 GLENDALE CA 91206 EMILY TAYLOR PRESIDENT CEO 7043640016 2024-05-13 true EMILY TAYLOR 999009999 LEWIS SHARPSTONE P02256953 8185701960 2024-05-13 X 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z X EMILY TAYLOR 350 N GLENDALE BLVD SUITE B STE 368 GLENDALE CA 91206 2037881 false X WWW.SOLVECFS.ORG X 1987 CA MAKE ME/CFS, LONG COVID AND OTHER POST-INFECTION DISEASES WIDELY UNDERSTOOD, DIAGNOSABLE, AND TREATABLE. 19 18 16 40 0 5519863 1989833 0 620 48048 0 5520483 2037881 157556 328632 0 1241048 1302793 0 660157 2067958 2181173 3466562 3812598 2053921 -1774717 3950139 2188069 430039 485906 3520100 1702163 X THE SOLVE ME/CFS INITIATIVE SOLVE M.E. IS A NON-PROFIT ORGANIZATION THAT SERVES AS A CATALYST FOR CRITICAL RESEARCH INTO DIAGNOSTICS, TREATMENTS, AND CURES FOR MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME ME/CFS, LONG COVID AND OTHER POST-INFECTION DISEASES. OUR WORK WITH THE SCIENTIFIC, MEDICAL, AND PHARMACEUTICAL CONTINUED SCH. O false false 1262557 328632 RESEARCH PROGRAMS - THE ORGANIZATION HAS DEVELOPED AND OPERATES THE DATABASE PLATFORM REGISTRY AND BIOBANK, AN OPEN-SOURCED RESEARCH TOOL IT DEVELOPED THAT IS DESIGNED TO HELP ADVANCE THE RESEARCH AND DEVELOPMENT OF DIAGNOSTICS AND TREATMENTS FOR ME/CFS. THE ORGANIZATION PROVIDED CURATED RESEARCH UPDATES BY EMAIL TO APPROXIMATELY 35,000 CONSTITUENTS AND CONTINUED TO EXPAND THE DATABASE PLATFORM REGISTRY CREATING THE WORLDS LARGEST LONGITUDINAL ME/CFS AND LONG COVID DATABASE, WITH NEARLY 7,000 PARTICIPANTS ENROLLED. INITIATED TRANSITION TO SOLVE TOGETHER, STATE-OF-THE-ART, PATIENT-DRIVEN DATA PLATFORM TO ENABLE RECRUITMENT FOR CLINICAL STUDIES. DATABASE PLATFORM ENROLLED PARTICIPANTS FOR 2 BIOMARKER STUDIES WITH EXTERNAL COLLABORATORS. THE ORGANIZATION ALSO PROVIDES SCIENTIFIC RESEARCH GRANTS FOR SCIENTISTS AND DOCTORS TO FIND CAUSES AND WAYS TO TREAT AND CURE POST INFECTION DISEASES LIKE ME/CFS AND LONG COVID. DURING THE YEAR ENDED JUNE 30, 2023, THE ORGANIZATION AWARDED RAMSAY RESEARCH GRANTS TO 6 SCIENTISTS AT ORGANIZATIONS IN THE US, NETHERLANDS, AND THE UK, CONT. ON SCH. O 1494937 ADVOCACY AND COMMUNICATION. THE ORGANIZATION WORKS WITH THE US CONGRESS TO INCREASE FUNDING FOR ME/CFS RESEARCH BY THE NATIONAL INSTITUTE OF HEALTH NIH, CENTER FOR DISEASE CONTROL CDC AND THE DEPARTMENT OF DEFENSE. DURING THE YEAR ENDED JUNE 30, 2023, MORE THAN 350 ADVOCATES PARTICIPATED IN OVER 220 VIRTUAL MEETINGS WITH MEMBERS OF CONGRESS AND THEIR STAFF AND OVER 6,300 VIRTUAL CONNECTIONS WERE MADE IN SUPPORT OF THE ORGANIZATIONS ADVOCACY GOALS. IN ADDITION, THE ORGANIZATION LAUNCHED A MAJOR NATIONAL AWARENESS CAMPAIGN. DEVELOPED A TV AND RADIO PUBLIC SERVICE ANNOUNCEMENT PSA DESCRIBING LONG COVID SYMPTOMS. WITH SUPPORT FROM THE ENTERTAINMENT BUSINESS FOUNDATION EIF AND DONATED AIR TIME, THE PSA SEGMENT WAS BROADCASTED 173,000 TIMES IN 2,200 MEDIA OUTLETS DURING THE YEAR, TO A TOTAL AUDIENCE EXPOSURE OF 1 BILLION PEOPLE. THE ORGANIZATION ALSO CONTINUED TO LEAD THE LONG COVID ALLIANCE THAT THE ORGANIZATION CO-FOUNDED, DELIVERING MONTHLY MEETINGS TO A COALITION OF APPROXIMATELY 1,000 LONG COVID AND ASSOCIATED CONDITIONS ORGANIZATIONS AND INDIVIDUALS FROM CONT ON SCH. O 2757494 true true false true false false false false false true true false false false true true true false false false true true false false false false false true false true false false false false false false false false false false false false false false false false false false false true X 12 0 16 true false false false false false false false false false false false false X 19 18 false false false false false false false true true false false true true true true true true true true true false CA CO IL MA MD MI MN NC NJ NY OR PA SC UT VA X X EMILY TAYLOR 7142961661 350 N GLENDALE BLVD STE B 368 GLENDALE CA 91206 OVED AMITAY PRESIDENT CEO 040.00 X X 185393 0 9941 EMILY TAYLOR DIRECTOR OF ADVOCACY AND COMMUNITY RELATIONS 040.00 X 123912 0 13122 TAKEISHA WALKER CHIEF OPERATING OFFICER 040.00 X 75214 0 3535 JOHN NICOLS CHAIR 005.00 X X 0 0 0 RICK SPROUT SECRETARY 004.00 X X 0 0 0 MIKE ATHERTON TREASURER 004.00 X X 0 0 0 BARBARA LUBASH VICE-CHAIR 004.00 X X 0 0 0 VICTORIA BOIES BOARD MEMBER 002.00 X 0 0 0 STEWART GITTELMAN BOARD MEMBER 002.00 X 0 0 0 WILLIAM HASSLER BOARD MEMBER 002.00 X 0 0 0 CAROL HEAD BOARD MEMBER 002.00 X 0 0 0 GURDYAL KALSI BOARD MEMBER 002.00 X 0 0 0 RONA KRAMER BOARD MEMBER 002.00 X 0 0 0 FERN OPPENHEIM BOARD MEMBER 002.00 X 0 0 0 AMRIT SHAHZAD BOARD MEMBER 002.00 X 0 0 0 JANICE STANTON BOARD MEMBER 002.00 X 0 0 0 KARL ZEILE BOARD MEMBER 002.00 X 0 0 0 CYNTHIA ADINIG BOARD MEMBER 002.00 X 0 0 0 JOSEPH BARRERA BOARD MEMBER 002.00 X 0 0 0 KENYA BECKMANN BOARD MEMBER 002.00 X 0 0 0 HUNTER HOWARD BOARD MEMBER 002.00 X 0 0 0 384519 26598 2 false true false DATA DRIVEN LLC - LESLIE EDITH PHILLIPS 3232 NE 89TH STREET SEATLE WA 98115 RESEARCH CONSULTING 173990 BOOM BROADCASTING INC 4 HILL SPRUCE LITTLETON CO 80127 PUBLIC SERVICE ANNOUNCEMENTS 251972 2 1989833 1989833 48048 48048 2037881 48048 X 104000 104000 0 224632 224632 0 390010 136632 181074 72304 0 767529 325597 9328 432604 28604 12478 2985 13141 31946 13039 336 18571 84704 34873 13001 36830 0 74441 74441 5219 5219 270000 270000 0 809673 809673 322778 322778 18337 3386 13486 1465 125256 56520 18840 49896 0 61279 24511 18384 18384 61602 41229 19589 784 0 96191 95892 299 0 0 0 17280 17280 PATIENT REGISTRY AND BIOBANK COSTS 157693 157693 PRINTING AND POSTAGE 93231 81072 1456 10703 DUES AND SUBSCRIPTIONS 35492 29191 826 5475 BANK FEES 20426 14298 6128 12275 12275 3812598 2757494 394947 660157 X 3663852 1747686 194013 320583 56377 77537 31552 31552 35897 42263 3950139 2188069 430039 485906 430039 485906 X 3426070 1502163 94030 200000 3520100 1702163 3950139 2188069 X -1774717 5965 -49185 X X false true X true false X 2594708 2235980 1998397 5519863 1989833 14338781 2594708 2235980 1998397 5519863 1989833 14338781 3309666 11029115 783 2037 6341 620 48048 57829 14396610 0.76610 0.74380 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true true false false false false true 301000 false false 301000 false II-B 1G THE BILLS INVOLVED WERE H.R. 1616 CARE FOR LONG COVID ACT, S.801 CARE FOR LONG COVID ACT 20305 937 21242 23023 -2718 20305 18030 4993 23023 18222 -192 18030 17222 1000 18222 1.00000 true false 31552 31552 Financial derivatives and other financial products Closely-held equity interests Federal income taxes X 2217932 5965 174086 180051 2037881 2037881 3986684 174086 174086 3812598 3812598 V 4 THE PURPOSE OF THE ORGANIZATIONS ENDOWMENT FUND IS TO SECURE THE FUTURE OF SOLVE M.E AND SUPPORT ITS PROGRAMS AND OPERATIONS. X 2 SOLVE M.E. IS INCORPORATED AS A NONPROFIT VOLUNTARY HEALTH AGENCY UNDER THE LAWS OF THE STATE OF NORTH CAROLINA AND QUALIFIED TO TRANSACT INTRASTATE BUSINESS IN THE STATE OF CALIFORNIA. FURTHER, SOLVE M.E. IS EXEMPT FROM FEDERAL INCOME TAX AS AN ORGANIZATION DESCRIBED IN SECTION 501C3 OF THE INTERNAL REVENUE CODE AND QUALIFIES AS A PUBLIC CHARITY UNDER CODE SECTIONS 509A1 AND 170B1AVI. ACCOUNTING STANDARDS REQUIRE AN ORGANIZATION TO EVALUATE ITS TAX POSITIONS AND PROVIDE FOR A LIABILITY FOR ANY POSITIONS THAT WOULD NOT BE CONSIDERED MORE LIKELY THAN NOT TO BE UPHELD UNDER A TAX AUTHORITY EXAMINATION. MANAGEMENT HAS EVALUATED ITS TAX POSITIONS AND HAS CONCLUDED THAT A PROVISION FOR A TAX LIABILITY IS NOT NECESSARY AT JUNE 30, 2023. GENERALLY, SOLVE M.E.S INFORMATION RETURNS REMAIN OPEN FOR EXAMINATION FOR A PERIOD OF THREE FEDERAL OR FOUR STATE OF CALIFORNIA YEARS FROM THE DATE OF FILING. true North America GRANTMAKING GRANTS TO RECIPIENTS LOCATED IN THE REGION 75694 South America GRANTMAKING GRANTS TO RECIPIENTS LOCATED IN THE REGION 19378 Europe Including Iceland and Greenland GRANTMAKING GRANTS TO RECIPIENTS LOCATED IN THE REGION 92369 Middle East and North Africa GRANTMAKING GRANTS TO RECIPIENTS LOCATED IN THE REGION 37191 224632 224632 North America MEDICAL RESEARCH IN BLOOD-BRAIN BARRIER IMAGING AS A BIOMARKER FOR MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME. 21500 WIRE Europe Including Iceland and Greenland MEDICAL RESEARCH IN MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME 40000 WIRE Europe Including Iceland and Greenland MEDICAL RESEARCH IN IMMUNOSENESCENCE AND PREMATURE AGEING OF THE IMMUNE SYSTEM IN ME/CFS 27369 WIRE Middle East and North Africa MEDICAL RESEARCH IN ENHANCED EXTERNAL COUNTERPULSATION EECP TO TREAT LONG-COVID FATIGUE - A RANDOMIZED CONTROLLED TRIAL 37191 WIRE South America SYMPTOMS, MECHANISMS AND SEX EXPLORING THE SEX DIFFERENCES IN ME/CFS THROUGH INTEGRATED COMPUTATIONAL ANALYSES 19378 WIRE Europe Including Iceland and Greenland MEDICAL RESEARCH IN POSSIBLE CLASS II MHC DEFICIENCY IN PATIENTS WITH MYALGIC ENCEPHALOMYELITIS OR CHRONIC FATIGUE SYNDROME ME/CFS 25000 WIRE North America MEDICAL RESEARCH IN PHYSIOLOGICAL AND COGNITIVE FUNCTION IN PATIENTS WITH POST ACUTE SEQUELAE OF SARS-COV-2 PASC OR MYALGIC ENCEPHALOMYELITIS ME BEFORE AND AFTER INSPIRATORY MUSCLE TRAINING 22530 WIRE North America MEDICAL RESEARCH ON EFFECT OF STELLATE GANGLION BLOCK ON ME/CFS SYMPTOMS AND PLASMA METABOLITES 31664 WIRE 7 1 false false false false false false Part I Line 2 RESEARCH GRANTEES ARE REQUIRED TO SUBMIT INTERIM REPORTS ON RESEARCH PROGRESS AND FINDINGS. true SIMMARON RESEARCH INC 948 INCLINE WAY INCLINE VILLAGE NV 89451 452191464 501C3 35000 MEDICAL RESEARCH IN THE AREA OF ME/CFS OR LONG COVID AND DESIRES TO CONDUCT A RESEARCH PROJECT ENTITLED TARGETING ATG13 IN ME/CFS. TEA LEAF HEALTH INC 2847 TURK BLVD SAN FRANCISCO CA 94118 271394052 501C3 5000 A PROOF OF CONCEPT STUDY TO ENRICH YOU ME REGISTRY DATA WITH CARE ACCESS AND SDOH PROFILES VASSAR COLLEGE 124 RAYMOND AVE POUGHKEEPSIE NY 12604 141338587 501C3 44000 MEDICAL RESEARCH IN MICROBIAL ARYL HYDROCARBON RECEPTOR AGONISTS IN ME/CFS FLORIDA ATLANTIC UNIVERSITY 777 GLADES RD BLDG 104 RM 334 BOCA RATON FL 33431 590917284 501C3 20000 MEDICAL RESEARCH ENDIGONOUS RETROVIRUS STUDY 4 Part I Line 2 RESEARCH GRANTEES ARE REQUIRED TO SUBMIT INTERIM REPORTS ON RESEARCH PROGRESS AND FINDINGS. X X X false false false false false false false false false OVED AMITAY PRESIDENT CEO 185393 9941 195334 Form 990, Part VI, Section B, Line 11B THE FINANCE COMMITTEE IS RESPONSIBLE FOR REVIEWING THE ORGANIZATIONS FORM 990 AND PROVIDING COMMENTS PRIOR TO IT BEING SUBMITTED TO THE INTERNAL REVENUE SERVICE. ALL MEMBERS OF THE BOARD OF DIRECTORS RECEIVE A COPY OF THE REVIEWED FORM 990 PRIOR TO ITS SUBMISSION TO THE IRS, BUT ARE NOT REQUIRED TO PROVIDE COMMENTS. Form 990, Part V, Section C, Line 19 THE ORGANIZATIONS FORM 990 AND ANNUAL REPORT ARE AVAILABLE ON ITS WEBSITE WWW.SOLVECFS.ORG. THE 990 IS ALSO AVAILABLE ON GUIDESTAR. UPON REQUEST THE ORGANIZATION WILL MAKE AVAILABLE COPIES OF ITS AUDITED FINANCIAL STATEMENTS, FORM 1023, GOVERNING BY-LAWS AND CONFLICTS OF INTEREST POLICY. Form 990, Part VI, Section B, Line 15A EMPLOYEES OF THE ORGANIZATION UNDERGO PERIODIC PERFORMANCE AND COMPENSATION REVIEWS. COMPENSATION LEVEL IS DETERMINED UPON PERFORMANCE, MARKET AND THE FINANCIAL POSITION OF THE ORGANIZATION. THE PRESIDENT PERFORMS ALL REVIEWS EXCEPT FOR THE POSITION OF PRESIDENT WHICH IS DONE BY MEMBERS OF THE PROFESSIONAL STAFF RECRUITING AND COMPENSATION COMMITTEE. THIS COMMITTEE IS COMPRISED OF THE EXECUTIVE COMMITTEE OF THE BOARD. TO ENSURE SALARY COMPENSATION IS COMPARABLE TO SIMILAR ORGANIZATIONS, THE COMMITTEE CONSULTS WITH PUBLISHED SALARY SURVEYS,. Form 990, Part VI, Section B, Line 15B THE PROCESS FOR DETERMINING THE COMPENSATION FOR THE KEY EMPLOYEE IS THE SAME AS DESCRIBED ABOVE ON LINE 15A. Form 990, Part VI, Section B, Line 12C DIRECTORS ARE REQUIRED TO SIGN ANNUAL CONFLICTS OF INTEREST FORMS, NOTIFY THE ORGANIZATION OF ANY CONFLICTS OF INTEREST AND RECUSE THEMSELVES FROM DISCUSSING OR VOTING ON ANY MATTERS WHICH ARE A CONFLICT FOR THEM. Form 990, Part IX, Line 11G OTHER FEES OTHER FEES REPRESENT FEES PAID TO LICENSED CONSULTANTS TO PERFORM PROGRAM RELATED SERVICES. Form 990, Part XII, Line 2B DURING 2023 THE ORGANIZATION CONTRACTED FOR A 6/30/2023 FINANCIAL STATEMENT AUDIT. HOWEVER, DUE TO VARIOUS FACTORS INCLUDING A CHANGE IN THE ORGANIZATIONS ACCOUNTING DEPARTMENT AND MANAGEMENT THE AUDIT WILL BE COMMENCED AFTER THE 990 FILING AND WILL BE COMPLETED, IN 2024. Form 990, Part XI, Line 8 DURING THE COURSE OF THE 2022 FISCAL YEAR AUDIT ADJUSTMENTS WERE IDENTIFIED THAT WERE NOT REFLECTED IN THE 2021 FORM 990. THE AGGREGATE AMOUNT OF THESE ADJUSTMENTS WAS 49,185. Form 990, Part X, Line 28 THE ORGANIZATIONS 6/30/23 990 TAX RETURN HAS BEEN PREPARED USING THE BEST INFORMATION READILY AVAILABLE. FOR EXAMPLE, THE ORGANIZATION HAS NOT TRACKED ITS NET ASSETS WITH DONOR RESTRICTIONS. ACCORDINGLY THE NUMBER ON PART X LINE 28 IS MANAGEMENTS BEST ESTIMATE OF THE BALANCE AT JUNE 30, 2023. Form 990, Part III, Line 4B CONTINUED AROUND THE WORLD ACROSS THE ADVOCACY, EDUCATION, FEDERAL POLICY AND SCIENTIFIC SPACES. Form 990, Part III, Line 1 CONTINUED COMMUNITIES, ADVOCACY WITH GOVERNMENT AGENCIES, AND ALLIANCES WITH PATIENT GROUPS AROUND THE WORLD ARE LAYING THE FOUNDATION FOR BREAKTHROUGHS THAT CAN IMPROVE THE LIVES OF MILLIONS WHO SUFFER FROM VARIOUS LONG HAUL DISEASES. Form 990, Part III, Line 4A CONTINUED SELECTED THROUGH A BLINDED PEER REVIEW PROCESS.